Methods of using (+)-1,4-dihydro-7-((3S,4S)-3-methoxy-4 - (methylamino)-1-pyrrolidinyl)-4-oxo-1-(2 - thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer

Details for Australian Patent Application No. 2006287149 (hide)

Owner Sunesis Pharmaceuticals, Inc.

Inventors Walker, Duncan; Adelman, Daniel C.; Arkin, Michael; Hyde, Jennifer; Silverman, Jeffrey A.; Wright, Jasmine

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006287149

PCT Pub. Number WO2007/028171

Priority 60/788,927 03.04.06 US; 11/218,387 02.09.05 US; 60/789,093 03.04.06 US; 11/218,653 02.09.05 US; 60/810,285 01.06.06 US

Filing date 5 September 2006

Wipo publication date 8 March 2007

International Classifications

A61K 31/4375 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/028171 Priority application(s): WO2007/028171

10 July 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read: FROM: Wright, Jasmine TO: Wright, Jasmin

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287152-A heating device

2006287141-Pay parking system and method